1.32
price up icon1.54%   0.02
after-market Handel nachbörslich: 1.32
loading

Acrivon Therapeutics Inc Aktie (ACRV) Neueste Nachrichten

pulisher
Aug 20, 2025

Is this a good reentry point in Acrivon Therapeutics Inc.Market Sentiment Report & Free Growth Oriented Trading Recommendations - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Acrivon Therapeutics Inc. Recovery Likely Here’s What Data ShowsPortfolio Performance Report & High Win Rate Trade Tips - kangso.co.kr

Aug 20, 2025
pulisher
Aug 20, 2025

Price Action Confirms Reversal in Acrivon Therapeutics Inc. TrendWeekly Stock Analysis & Consistent Income Trade Recommendations - classian.co.kr

Aug 20, 2025
pulisher
Aug 20, 2025

ACR-368 OncoSignature assay gains FDA breakthrough status - MSN

Aug 20, 2025
pulisher
Aug 20, 2025

Is Acrivon Therapeutics Inc. stock a good hedge against inflation2025 Market Outlook & Capital Efficient Trade Techniques - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Using fundamentals and technicals on Acrivon Therapeutics Inc.July 2025 Snapshot & Reliable Entry Point Trade Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Acrivon Therapeutics Inc. stock chart pattern explained2025 Technical Patterns & Consistent Income Trade Recommendations - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Real time breakdown of Acrivon Therapeutics Inc. stock performance2025 Investor Takeaways & Real-Time Sentiment Analysis - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

What indicators show strength in Acrivon Therapeutics Inc.July 2025 Drop Watch & Comprehensive Market Scan Insights - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Acrivon Therapeutics Inc. stock prediction for this weekMarket Activity Recap & Weekly Sector Rotation Insights - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Visual analytics tools that track Acrivon Therapeutics Inc. performanceJuly 2025 Selloffs & Precise Swing Trade Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Smart tools for monitoring Acrivon Therapeutics Inc.’s price actionWeekly Stock Recap & Low Risk Entry Point Guides - Newser

Aug 20, 2025
pulisher
Aug 19, 2025

Full technical analysis of Acrivon Therapeutics Inc. stockJuly 2025 Catalysts & Fast Exit Strategy with Risk Control - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

What does recent volatility data suggest for Acrivon Therapeutics Inc.Earnings Trend Report & Expert Approved Momentum Ideas - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Why Acrivon Therapeutics Inc. is moving todayRecession Risk & Weekly High Potential Stock Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

How to recover losses in Acrivon Therapeutics Inc. stockEarnings Summary Report & Consistent Income Trade Recommendations - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

How institutional ownership impacts Acrivon Therapeutics Inc. stockQuarterly Market Review & Capital Efficiency Focused Strategies - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Can volume confirm reversal in Acrivon Therapeutics Inc.July 2025 Patterns & Risk Controlled Swing Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Understanding Acrivon Therapeutics Inc.’s price movementJuly 2025 Action & Technical Pattern Based Buy Signals - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Published on: 2025-08-19 01:37:39 - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Best data tools to analyze Acrivon Therapeutics Inc. stockWeekly Risk Report & Consistent Income Trade Ideas - Newser

Aug 19, 2025
pulisher
Aug 18, 2025

Relative strength of Acrivon Therapeutics Inc. in sector analysisTrade Signal Summary & AI Forecasted Entry/Exit Points - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Acrivon Therapeutics Inc. Company Revenue and Profit Trends: A Deep Dive2025 Price Action Summary & Fast Entry Momentum Alerts - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Acrivon Therapeutics’ SWOT analysis: precision medicine stock faces pivotal trials - Investing.com

Aug 18, 2025
pulisher
Aug 18, 2025

Research Analysts Set Expectations for ACRV Q3 Earnings - Defense World

Aug 18, 2025
pulisher
Aug 17, 2025

Momentum divergence signals in Acrivon Therapeutics Inc. chartWeekly Trade Review & High Win Rate Trade Alerts - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Is Acrivon Therapeutics Inc. stock entering bullish territoryWeekly Risk Report & Weekly Top Gainers Trade List - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Is Acrivon Therapeutics Inc. forming a double bottomQuarterly Performance Summary & Low Risk Entry Point Tips - 선데이타임즈

Aug 17, 2025
pulisher
Aug 16, 2025

Historical volatility pattern of Acrivon Therapeutics Inc. visualizedOil Prices & Free Technical Pattern Based Buy Signals - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Is Acrivon Therapeutics Inc. a potential multi baggerDip Buying & Technical Pattern Recognition Alerts - thegnnews.com

Aug 16, 2025
pulisher
Aug 16, 2025

Is Acrivon Therapeutics Inc. stock a smart retirement pick2025 Price Targets & Weekly Momentum Stock Picks - newsyoung.net

Aug 16, 2025
pulisher
Aug 16, 2025

Acrivon Therapeutics, Inc.: Promising Clinical Developments and Strong Financial Position Justify Buy Rating - TipRanks

Aug 16, 2025
pulisher
Aug 16, 2025

Detecting support and resistance levels for Acrivon Therapeutics Inc.Quarterly Investment Review & Low Drawdown Momentum Ideas - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Real time alert setup for Acrivon Therapeutics Inc. performanceMarket Volume Summary & Technical Pattern Alert System - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Why Acrivon Therapeutics Inc. stock attracts strong analyst attentionWatch List & Weekly Momentum Picks - Newser

Aug 16, 2025
pulisher
Aug 15, 2025

Short interest data insights for Acrivon Therapeutics Inc.Fed Meeting & Real-Time Buy Signal Alerts - Newser

Aug 15, 2025
$36.31
price down icon 1.55%
$86.53
price up icon 0.38%
$26.01
price up icon 0.54%
$110.77
price down icon 0.48%
$132.60
price up icon 2.43%
biotechnology ONC
$313.97
price up icon 1.50%
Kapitalisierung:     |  Volumen (24h):